Prana Biotech Plunges as Drug Fails in Alzheimer Study

Prana Biotechnology Ltd. plunged the most ever in New York after the company’s experimental drug for Alzheimer’s disease failed to help patients in a trial.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.